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1. Introduction  
Magnetic particles have a significant role in nanotechnology due to their surface properties 
and their applicability in physical and chemical processes like ionic exchange, specific 
complexation, biocompatibility and bioactivity, capacity of selection and transport for cells 
and chemical compounds (Safarik & Safarikova, 2002). 
Magnetite is an interesting superparamagnetic nanomaterial, considered as a challenge by 
the modern research related magnetic applications, due to its high susceptibility at oxidation 
as compared to other magnetic compounds (Cornell & Schwertmann, 1996).  
The name “superparamagnetic” refers to those particles that in presence of magnetic field 
are attracted and in absence of the magnetic field the particles don’t have residual 
magnetism. The importance of magnetite particles is related to their most important 
properties - magnetic and catalytic. These properties are strongly dependent on the selected 
method of preparation.  
These magnetic particles are used in many applications that involve their immobilization 
and transport in the presence of magnetic field, or magnetically tagged biological entities 
due to the intrinsic penetrability of magnetic fields into human tissue. 
The chapter describes the most important approaches in the preparation of magnetite 
particles, as presented in the literature. An introspective view of biomedical, industrial and 
catalytic applications of magnetite micro- and nanoparticles is also reported. 
The magnetite particles are usually attracted to each other. Electrostatic or steric 
stabilization represent the main step in obtaining “core-shell” magnetic particles with 
magnetite core and a shell formed by different surfactants. We summarize here some 
examples and also some data previously reported by our group (figure 1) on the preparation 
of magnetite particles coated by different Si-containing compounds (monomers and 
polymers) (Durdureanu-Angheluta et al., 2008; Durdureanu-Angheluta et al., 2009; 
Durdureanu-Angheluta et al., 2010; Pricop et al., 2010). 
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Fig. 1. Schematic representation of the preparation of core-shell magnetite particles with 
different Si-containing compounds. 
2. Synthesis methods 
Magnetite particles are quite intriguing, due to their catalytic and magnetic properties 
strongly dependent on the chosen synthesis method. Several methods are described in the 
literature, but in the present manuscript we are going to focus on the most common ones: 
iron salts co-precipitation (Massart, 1981; Martinez-Mera et al., 2007), sol-gel reaction, micro-
emulsion (Woo et al., 2003), reaction in mass without solvent (Ye et al., 2006), polyols 
process (Feldmann & Jungk, 2001), decomposition of iron pentacarbonyl (Shafi et al., 2001), 
etc.  
2.1 Co-precipitation  
The synthesis by co-precipitation is the easiest way to obtain iron oxides like magnetite 
(Fe3O4) (Laurent et al., 2008) or like maghemite (Ǆ-Fe2O3) and has shown to be a highly 
economic and versatile method. We used the method described by Massart (Massart, 1981) 
involving the co-precipitation of two iron salts FeCl36H2O and FeCl24H2O, both prepared 
in HCl, with the consequent addition of a NH4OH solution, vigorous stirring and under 
anoxic conditions, at room temperature. The shift of the initially orange color of the solution 
to black indicates the formation of magnetite particles. The surface of magnetite particles, in 
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contact with a neutral aqueous solution is able to adsorb OH- and H-, respectively, giving an 
OH- rich surface (Durdureanu-Angheluta et al., 2008). 
The reaction for obtaining magnetite is given below: 
 2FeCl3 + FeCl2 + 8NH3 + 4H2O → Fe3O4 + 8NH4Cl (1) 
The disadvantage of the co-precipitation process is that the control of particle size 
distribution is limited, due to kinetic factors that are controlling the growth of the crystal. 
Two stages are involved in the co-precipitation process (Cornell & Schwertmann, 1996; 
Boistelle et al., 1988; Sugimoto, 2003; Cornell et al., 1991; Gribanow et al., 1990): nucleation 
that occurs when the concentration of the species reaches critical supersaturation, and a 
slow growth of the nuclei by diffusion of the solutes to the surface of the crystal. To produce 
monodisperse iron oxide nanoparticles, these two stages should be separated. Nucleation 
should be avoided during the period of growth (Tartaj et al., 2006). 
An alternative route to obtain magnetite particles by co-precipitation is the method 
described by Kim et al. (Kim et al., 2001) and Koneracka et al. (Koneracka et al., 2002) 
involving the preparation of the two solutions of ferric chloride (FeCl36H2O) and ferrous 
sulphate (FeSO4) by dissolution in a HCl solution at room temperature under vigorous 
stirring using a mechanical stirrer. The solutions are mixed and an aqueous dispersion of 
particles is obtained after adding a solution of NaOH under sonication or under vigorous 
mechanical stirring.  
Magnetic particles are prepared, also, using FeCl36H2O and FeSO47H2O salts in aqueous 
solutions, both added in a polymeric starch matrix at 800C under nitrogen atmosphere and 
vigorous stirring (Jiang et al., 2009). NaOH should be added to the mixture until reaching a 
basic pH (9-11) and the black precipitate is neutralized with HCl.  
2.2 Sol-gel reaction  
The reaction takes place at the water/oil interface. An aqueous solution containing Fe2+/Fe3+ 
salts is added to an organic solvent containing the stabilizer. The sol-gel reaction is 
performed at room temperature and is based on the hydroxylation and condensation of 
molecular precursors in solution and leads to a three-dimensional metal oxide network, the 
wet gel. Heat treatments are further needed to acquire the final crystalline state (Liu et al., 
1997; Kojima et al., 1997). The properties of the gel are dependent on the structure created 
during the sol stage of the sol-gel process. 
Sol-gel nanocomposite materials (FexOy-SiO2) were obtained using alkoxide and aqueous 
routes (Raileanu et al., 2003). The structure and properties of the prepared particles were 
compared for different precursors of silica (tetramethoxysilane, methyltriethoxysilane, 
colloidal silica solution, etc.).  
Magnetite-based ferrofluids were synthesized through a modified sol–gel method (Gamarra 
et al., 2005). They precipitated iron oxyhydroxy in water in the presence of a surfactant 
(Renex), and next they partiallly reduced Fe3+ to Fe2+ by a mild drying process in N2 
atmosphere, leading to the formation of magnetite. 
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2.3 Free-solvent synthesis  
The free-solvent synthesis of magnetite is an economical and non-toxic method. The solid 
iron salts (FeCl36H2O and FeCl24H2O) and a solid base (NaOH) are used directly with the 
surfactant and mixed together using a mortar and a pestle (Ye et al., 2006). The synthesis 
procedure takes place at room temperature in a glove box filled with argon gas. This 
method is easy, without any advanced techniques and toxic solvents. The reaction duration 
is about a few minutes and the high yield magnetite obtained is monodisperse.  
2.4 Other methods 
Polyol process  
Polyols are known to reduce metal salts to metal particles and to be good solvents for 
various inorganic compounds. This is why the synthesis of nano- and microparticles with 
well-defined shapes and controlled sizes can be performed by the polyol process, also 
(Fievet et al., 1989). The metal precursor is heated to a given temperature which cannot be 
higher than the boiling point of the polyols, with generation of intermediates that are 
reduced to metal nuclei and nucleate to form metal particles. Polyols act like solvents due to 
their high dielectric constants and like surfactants, preventing the particles aggregation. 
Their high boiling points offer the advantages of operating on a large temperature interval 
(from 250C up to the boiling point). The “core-shell” PVP (poly(vinylpyrrolidone))-
nanoparticles can be obtained in one-pot polyol process by reduction of Fe(acac)3 with 1,2-
hexadecanediol in the presence of the PVP polymer surfactant in octyl ether (Liu et al., 
2007). These particles are promising for biomedical applications like MRI agents and 
biosensors. The magnetite nanoparticles prepared by this method have a long-term stability 
and are easily coated by various materials to generate multifunctional nanoparticles. Non-
aggregated magnetite nanoparticles have been already synthesized in liquid polyols at 
elevated temperature (Cai et al., 2007). Highly performance magnetite nanoparticles have 
been also obtained by a modified polyol process. For that, only one iron rich precursor has 
been used and no further reducing agent and surfactants were required. The magnetite 
nanoparticles can be coated in situ by hydrophilic polyol ligands, and the hydrophilic 
triethylene glycol magnetic nanoparticles are easily dispersed in water and other polar 
solvents. This method is a good alternative to produce superparamagnetic water-soluble 
magnetic nanoparticles and can replace the co-precipitation method.  
Micro-emulsion  
Emulsions are thermodynamically stable and consist of two different immiscible liquids 
(like oil - organic solvent and water) (Bagwe et al., 2001). The emulsion is stabilized by 
adding a surfactant. The size of magnetite particles synthesized by micro-emulsion method 
is several nanometers in diameter (López Pérez et al., 1997), except in some specific cases 
(20-30 nm) (Hirai et al., 1997). This method is difficult to control, the obtained yield is low 
and the particles are polydisperse. The commonly used method is the one that involves 
water-in-oil micro-emulsion and also includes a reverse micelle system (Ganguli et al., 2003). 
For the synthesis of Fe3O4, the precipitation technique consisting of alkalization of a solution 
of metal salt and hydrolysis in micro-emulsions (Boal et al., 2004; Hirai et al., 1997) is 
commonly used, as well as biosynthetic routes (Matsunaga, 1998).  
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Magnetite/silica particles were prepared by reverse-micelle micro-emulsions in an organic 
phase such as cyclohexane and heptane (Yang et al., 2004; Santra et al., 2001). 
Fe3O4 nanoparticles in poly(organosilsesquioxane) with sizes of 4-15 nm were prepared by 
the one-pot synthesis using reverse micelle method (Ervithayasuporn et al., 2009). The 
ferrofluid droplets were in situ encapsulated, via polycondensation of molecularly self-
assembled octenyltrimethoxysilane.  
Sonochemical decomposition of iron pentacarbonyl  
Magnetite nanoparticles were obtained by a sonochemical micro-emulsion polymerization 
process of n-butyl methacrylate (BMA) monomer (Teo et al., 2009). Iron tri(acetylacetonate), 
1,2-tetradecanediol, oleic acid, and oleyl amine were mixed in benzyl ether, under vigorous 
stirring. The mixture was heated gradually under nitrogen atmosphere and the black-
colored mixture was then cooled to room temperature by removing the heat source. The 
pre-formed particles were then encapsulated within the host poly(BMA) latex particles with 
120 nm diameter and low size dispersion. The distribution of magnetite particles over the 
polymer particle population and within each polymer particle was nevertheless rather 
heterogeneous and the ratio of magnetite particles per polymer particle was determined as 
being equal to 50. 
3. Influence of Fe2+ onto magnetite properties 
The stoechiometric factor of Fe2+ and Fe3+ is important for the magnetic properties of the 
obtained particles (coercivity, crystallinity, sorbtion capacity, etc.) (Gorski et al., 2010). The 
Fe2+ chemical species direct the magnetite particles synthesis kinetics and their composition 
(Tronc et al., 1992). The Fe2+/Fe3+ molar ratio is highly important if one focusses on 
obtaining magnetite particles with specific properties. Thus, a Fe2+/Fe3+<0.l molar ratio is 
too small to achieve a stable solution. In this context, if the content of chemical species of 
Fe2+ is low, goethite (ǂ-FeO(OH)) is obtained as the only stable product. The use of the 
Fe2+/Fe3+>0.1 molar ratio is favorable for obtaining magnetite instead of goethite.  
The influence of the Fe2+/Fe3+ molar ratio on the characteristics of magnetite particles 
obtained by co-precipitation of Fe2+ and Fe3+ (composition, size, morphology and magnetic 
properties) was studied by Jolivet (Jolivet et al., 1992). Chemical species in different 
proportions were precipitated with ammonia solution to pH~11. The analysis of the 
products obtained with different Fe2+/Fe3+ molar ratios, in the range 0.10-0.50, concluded 
that for values lower than 0.30 two different phases coexist:  
(a) the first phase contains particles of 4 nm in diameter, with oxyhydroxy (FeO(OH)) 
surface functional groups and low Fe2+ content, reflected by the ratio Fe2+/Fe3+~0.07;  
(b) the second phase is characterized by increased content of Fe2+ (Fe2+/Fe3+~0.33 molar 
ratio), the final product is magnetite with increased particle sizes. It was noticed that the 
share of this phase increases with increasing the Fe2+/Fe3+ molar ratio. Thus, for values 
greater than 0.35, the product is found only in the second phase.   
In conclusion, for a 0.5 Fe2+/Fe3+ molar ratio homogenous magnetite particles of uniform 
size and composition are more likely to be obtained. The order of addition of ionic species 
(Fe2+ and Fe3+) in co-precipitation reaction does not influence the final characteristics (size, 
composition) of the obtained particles. 
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The influence of ionic species concentrations on the properties of magnetite particles was 
also followed. It was noted that the Fe2+/Fe3+ molar ratio was a determining factor in 
obtaining sub-micron sizes, while by increasing the ratio, the mean diameter of the magnetic 
particles increased, but unfortunately the yield decreased (Babes et al., 1999).  
4. Sterically functionalized magnetite core-shell particles 
Magnetite surface chemistry 
Magnetite particles act as Lewis acids in aqueous systems and coordinate water or hydroxyl 
groups. This is why the particles surface chemistry is highly dependent of pH value; at low 
pH the surface of the particles is protonated and at high pH the surface is negatively 
charged (Figure 2). The hydroxyl groups from magnetite surface are the reactive parts, 
which can react with acid or base. The HO- groups are reacting with other organic or 
inorganic anions and may adsorb protons or cations, also. 
 
Fig. 2. Magnetite particles behavior at low/high pH. 
Magnetic ferrofluids based on magnetite particles have a high capacity of agglomeration 
due to the fact that two types of forces co-exist: attraction and repulsive forces. The 
stabilization of the magnetic particles requires the control of these forces. To obtain stable 
magnetic dispersions, the attraction forces between magnetic particles must be overcomed 
by electrostatic or steric stabilization (Figure 3).  
 
Fig. 3. Electrostatic (a) and steric (b) stabilization of the particles. 
In order to stabilize magnetite particles, monomers/polymers with functional groups that 
can bind to the surface of the particles and act as surfactants can be used. The rest of the 
chain is solvated in dispersion medium or in a fluid. The process, known to be entropic or 
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steric, refers to the inhibition of particles aggregation by an entropic force, which appears 
when the particles are closed to each other. As surfactants monomers, homopolymers, block 
copolymers and polymers with terminal functional groups can be successfully used. After 
the coating process, these particles are re-suspended in proper solvents and form 
homogenous suspensions named ferrofluids (Shen et al., 2004). 
 
Magnetite 
particles 
precursors 
Coating agent Diameter
(nm) 
Type of 
linkage 
Reference 
Fe(CO)5 Polyethylene, Polystyrene, 
Polyisobutylene - all three 
functionalized with 
tetraethylenepentamine
8-50
 
 
 
 
 
 
 
 
 
Hydrogen 
bond 
 
Burke et al., 2002 
FeCl24H2O 
FeCl36H2O 
Oleic acid, Stearic acid, Linoleic 
acid
5.7-9.3 Korolev et al., 2002 
FeSO4 
FeCl3 
N-oleoylsarcosine 8.1-20.7 Xu et al., 2004 
FeCl24H2O 
FeCl36H2O 
 
Double shell with oleic acid -
Pluronic F-127, and then 
entrapped the doxorubicin
193 (DLS)
11 (TEM) 
9.2 (XRD)
Jain et al., 2005 
 
FeCl36H2O 
FeSO46H2O 
Xylan 25.26±0.42 
µm
Andriola Silva et al., 
2007
FeCl24H2O 
FeCl36H2O 
Carboxyethylsilanetriol sodium 
salt solution 
 
10 
(magnetite) 
100 (core-
shell 
particles)
Kobayashi et al., 
2008 
 
FeCl24H2O 
FeCl36H2O 
Ricinoleic acid and Poly(lactic-co-
glycolic) acid (PLGA)
140-230 Furlan et al., 2010 
FeCl24H2O 
FeCl36H2O 
Double shell: silica (SiO2/Fe3O4) 
and aluminosilicate
100 Chang et al.,  
2009
FeCl3 
Na2SO3 
Ethoxy-PEGsilane
 
N-hydroxysuccinimide PEG-
fluorescein 
Folic acid 
10 
(magnetite) 
Covalent 
bond 
 
Covalent 
bond 
Hydrogen 
bond
Zhang et al., 2002 
 
FeCl24H2O 
FeCl36H2O 
 
3-aminopropyltrimethoxy silane 
(APTMS) 
and monomethoxy-poly(ethylene 
glycol) (MPEG) 
(CH3CH2O)3-Si-MPEG
200 
 
 
 
 
Covalent 
bond 
 
Kim et al., 2002 
 
FeCl36H2O 
FeSO47H2O 
3-aminopropyltrimethoxy silane 
(APTES) 
and Polyethylene glycol diacid 
(HOOC–PEG–COOH)
40-60 Feng et al.,  
 2008 
FeSO47H2O Tetraethoxyorthosilicate (TEOS) 
(OEt)4Si 
3-aminopropyl) triethoxysilane 
(APTES) 
CS2, NaOH and 2-propanol
50-80 Girginova et al., 2010 
 
Table 1. Core-shell magnetite particles. 
www.intechopen.com
 Materials Science and Technology 
 
156 
The synthesis methods for magnetic particles with magnetite core and monomer/polymer 
shell, named core-shell magnetic particles, are presented in the literature (Table 1). The 
surfactant used must have functional groups to interact by hydrogen or covalent bonds 
(Figure 4) with the hydroxilic groups from pre-formed magnetite surface (trialkoxysilanes or 
compounds with carboxylic groups) (Kazufumi et al., 2008; Wormuth, 2001; Mondini et al., 
2008; Shukla et al., 2007; Wilson et al., 2005) and other functional groups to permit their 
dispersing in a transport fluid (aminic, epoxy, vinyl groups, etc.). 
  
                                                     (a)                                                             (b) 
Fig. 4. Schematic representation of hydrogen bond (a) and covalent bond (b) between core 
and shell. 
5. Applications of micro- and nanomagnetite particles 
The high interest for magnetic particles (ferrofluids, nanospheres and microspheres) can be 
explained due to their various applications, e.g., in magnetic storage devices or magnetic 
cell separations (Goya et al., 2003). The magnetic particles were also tested for cancer 
treatment and as drug and nucleic acids carriers (Lubbe et al., 1996).  
Top domains for multiple applications of micro- and nanoparticles with magnetic properties 
are biomedical applications, catalysis and industrial applications. 
5.1 Biomedical applications  
Magnetite nanoparticles represent an intriguing material for various researchers, due to 
their biomedical applications in the treatment of solid tumours (Gomez-Lopera, 2006) or 
contrast agents (Frija et al., 2004). In order to be efficient in biological applications, colloidal 
suspensions of magnetic particles must have long-time stability and the magnetic core must 
respond to an external magnetic field that directs the particle to a desired location. Colloidal 
stability is influenced by the size, structure and composition of the particle with a narrow 
dimensional controlled polydispersity. All these requirements lead to magnetic fluids that 
flow through the capillaries that provide a maximum diameter of 1.4 µm. The colloidal 
stability of magnetite particles is insured by coating the magnetic core with a monomer or 
(co)polymer, as surfactant, to have the particles dispersed in a carrier fluid.  
Magnetite (Fe3O4) nanoparticles that exhibit excellent magnetic saturation (~78 emu/g) are 
desirable for these applications due to the strong ferromagnetic behaviour, lower sensitivity 
to oxidation and relatively low toxicity as compared to many other materials (e.g., iron, 
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nickel and cobalt) (O’Brien, 2003). Magnetite has been intensively studied in the past 
decades due to its application in biotechnology and biomedicine: cancer treatment (Jordan et 
al, 2001, Jordan et al., 1999, Herrera et al., 2008), sensors, catalysis, storage media, clinical 
diagnosis and treatment of some diseases (Torchilin et al., 2001, Jordan et al., 2001).  
Especially for biomedical application, the particles must present some specific properties 
like:  
1. Magnetic properties 
In order to respond to an external magnetic field magnetic particles must have a large 
saturation magnetization, an important characteristic for targeted drug delivery systems 
and contrast agents for MRI (magnetic resonance imaging) (Bulte, 2006, Modo et al., 2005, 
Burtea et al., 2005, Boutry et al., 2006, Babes et al., 1999, Sonvico et al., 2005, Corot et al., 
2006, Corot et al., 2007)). In the presence of an external magnetic field the magnetic moments 
are oriented with the field (Figure 5). Magnetic nanoparticles modified with organic 
molecules and used for biomedical applications can be magnetically controlled by applying 
an external magnetic field. 
2. Stability in colloidal dispersions  
The stability of the particles can be enhanced by coating with biocompatible surfactants (Ma 
et al., 2003) capable of interactions with hydroxyl groups on the magnetite surface and 
ensuring the ferrofluid stability. The coating agent should have specific functional groups 
for further functionalization for specific applications. 
3. Nano- sized dimensions 
The magnetic particles with biomedical applications must have controllable sizes ranging 
from a few nanometres up to tens of nanometres, smaller than those of a cell (10–100 μm) 
(Pankhurst et al., 2003), a virus (20–450 nm), a protein (5–50 nm) or a gene (2 nm wide and 
10–100 nm long) because they can ‘get close’ to a biological entity of interest. Magnetic 
particles encapsulated into a polymer matrix with dimensions more than 1 µm or sub-
micron is more effective in the bloodstream through the veins or arteries (Lazaro et al., 
2005). 
4. Oxidation stability 
Metals such as Fe, Co and Ni, which oxidize easily, are not recommended in biomedical 
uses due to the higher probability of oxidizing inside human bodies. This problem can be 
solved using magnetite particles that not only present a greater stability to oxidation,  
but can be coated with different specific surfactants, increasing their resistance to  
oxidation. 
The polymers used as surfactants can be synthetic or natural molecules able to yield stable 
colloidal suspensions designed for drug delivery. Nevertheless, synthetic polymers have the 
advantage of high purity and reproducibility over natural polymers.  
The colloidal magnetic particles obtained for biomedical application (Asmatulu et al., 2005) 
as targeted drug delivery will have to pass through a few mechanisms of releasing drug 
molecules: diffusion, degradation of polymeric shell, swelling of the shell followed by 
diffusion of active principle outside the magnetic particle. The diffusion involves drug 
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molecules dissolving in body fluids around or within the particles and migration of the drug 
away from the particles. The degradation mechanism occurs when the polymer chains are 
hydrolysed into lower molecular weight species and release the drug trapped by the 
polymer chains. The coated particles, when inside the body, swell to increase pressure, and 
the drug diffuses from the polymer network into the body.   
 
 
 
 
 
Fig. 5. Magnetite particles in presence/in absence of magnetic field. 
Magnetic nanoparticles coated with different organic compounds offer a high potential for 
numerous biomedical applications, such as cell separation (Kuhara et al., 2004), automated 
DNA extraction (Yoza et al., 2003), gene targeting (Plank et al., 2003), drug delivery (Lazaro 
et al., 2005), magnetic resonance imaging (Glech et al., 2005), and hyperthermia (Pardoe et 
al., 2003). After coating with an antibody, they can be used for immunoassays (Chemla et al., 
2000) or small substance recovery (Tanaka et al., 2004). DNA or oligonucleotides 
immobilized on magnetic particles have been used for DNA hybridization analyses to 
identify organisms (Matsunaga et al., 2001) and single-nucleotide polymorphism analyses 
for human blood (Maruyama  et al., 2004). 
Magnetic particles coated with immunospecific agents have been successfully bound to red 
blood cells (Molday et al., 1982, Tibbe et al., 1999), lung cancer cells (Kularatne et al., 2002), 
bacteria (Morisada et al., 2002), urological cancer cells (Zigeuner  et al., 2003). Coupling of 
homing peptide labeled with 5-carboxyl-fluorescein (FAM-A54) and magnetite coated with 
starch chains functionalized with homing peptide was performed by Schiffs’ reaction (Jiang 
et al., 2009). This magnetic fluid has great potential applications in diagnostics and 
therapeutics of human tumours. 
Nano-sized iron oxide particles (Fe3O4) were coated with a lipid layer and then 
functionalized with biotin for further protein ligands. These particles were then used for 
binding streptavidin–fluorescein isothiocyanate generating a conjugate used to investigate 
their magnetic and fluorescent activity into cells (Beckera et al., 2007). 
The magnetic particle application for hyperthermia goes back to 1957 (Gilchrist et al., 
1957). The authors heated up various damaged tissue samples with 20–100 nm size 
particles of Ǆ -Fe2O3 exposed to a 1.2 MHz magnetic field. Since then the scientists have 
been developing numerous methods and schemes using different types of magnetic 
materials, different field strengths and frequencies of encapsulation and delivery of the 
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particles (Mosso et al., 1973, Rand et al., 1976, Gordon et al., 1979, Rand et al., 1981, 
Borrelli et al., 1984, Hase et al., 1990, Suzuki et al., 1990, Chan et al., 1993, Matsuki et al., 
1994, Mitsumori et al., 1994, Suzuki et al., 1995, Moroz et al., 2001, Jones et al., 2002). The 
hyperthermia procedure involves the dispersion of the magnetic particles throughout the 
target tissue, followed by applying an AC magnetic field with specific parameters 
(frequency, strength); the magnetization of the particles is continuously reversed, which 
translates into a conversion from magnetic to thermal energy and causes the heating of 
particles. The tumour is destroyed if the temperature is maintained above the therapeutic 
threshold of 420C for 30 min or more.  
The bisphosphonate modified magnetite nanoparticles were used as agents to remove 
uranyl ions (e.g., UO22+) in vivo from water or blood (Wang et al., 2006). The authors 
synthesized a bisphosphonate derivative, DA-BP, which modifies the magnetite 
nanoparticles for the successful decorporation of the radioactive metal from blood due to 
the chelating effect (Fukuda, 2005). Starting from this study, a protocol that allows the 
detection and recovery of other heavy metal toxins from the biological systems has been 
developed and perfected.  
Coated magnetite particles with magnetic resonance, fluorescent imaging and drug delivery 
applications were obtained (Kim et al., 2008). The particles obtained are monodisperse, with 
dimensions smaller than 100 nm, coated with silica shell using cetyltrimethylammonium 
bromide as surfactant for the transfer of hydrophobic nanocrystals to aqueous media and 
also as organic template in the sol-gel reaction. The silica-Fe3O4 particles were functionalized 
with PEG for further biomedical applications in cancer diagnosis and therapy.  
Magnetite particles (nanoparticles with 5–300 nm or microparticles with 300–5,000 nm) have 
been surface functionalized and used as biosensors to recognize specific molecular targets. 
Three types of biosensors, (i) magnetic relaxation witches, (ii) magnetic particle relaxation 
sensors, and (iii) magnetoresistive sensors, were coated with different biosensing principles 
and magnetic materials for instrumentation (Josephson, 2009). Magnetic relaxation switch 
assay-sensors are based on the effects of the magnetic particles exert on water proton 
relaxation rates. Magnetic particle relaxation sensors determine the relaxation of the 
magnetic moment within the magnetic particle. Magnetoresistive sensors detect the 
presence of magnetic particles on the surface of electronic devices and are sensitive to 
changes in magnetic fields on their surface.  
Magnetic resonance imaging (MRI) is a non-invasive technique without radiations 
exposure that can provide cross-sectional images from inside the solid materials and 
living organisms (Kim et al., 2003, Richardson et al., 2005). Magnetite nanoparticles are 
suitable for MRI contrast (Bean et al., 1959, Koenig et al., 1987). Magnetite particles have 
been proposed for oral use as magnetic resonance contrast agents and magnetic markers 
to study the gastrointestinal motility (Briggs et al., 1997, Ferreira et al., 2004). The gastric 
secretions include pepsin, mucus, and HCl (Paulev, 1999-2000) and magnetite particle 
dissolution may take place during their passing through the stomach. This could reduce 
the signal for MRI or for monitoring gastrointestinal motility. The problem that appears in 
this domain is to protect compounds from gastric environment and the xylan is a good 
candidate for this issue. Xylans are polysaccharides made from units of xylose and can be 
found as structural components in the cell walls of some green algae. Xylan-coated 
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magnetic microparticles were obtained (Andriola Silva et al., 2007) to protect magnetite 
from gastric dissolution.  
5.2 Applications in catalysis 
The aim of the catalysis is to search new catalysts that can be recovered when their activity 
is ended (Sankaranarayanapillai et al., 2010). The magnetic dispersions are attractive in 
separation applications as they offer high surface area and can be functionalized to apply to 
different molecular or cellular species. The magnetic fluids can be used as magnetically 
separable nanocatalytic systems that combine the advantages of homogeneous and 
heterogeneous catalysis (Lu et al., 2004). Novel thermoreversible magnetic fluids based on 
magnetite (Fe3O4) coated with a covalently anchored polymeric shell of poly(2-methoxyethyl 
methacrylate) (PMEMA) were synthesized by surface-initiated ATRP (Gelbrich et al., 2006). 
The coated particles form stable dispersions in methanol at temperatures above an upper 
critical solution temperature.  
Magnetically recoverable heterogenized nanoparticle supported chiral Ru complexes were 
obtained and used in highly enantioselective asymmetric hydrogenation of aromatic ketones 
(Hu et al., 2005). The catalysts can be recycled by magnetic decantation and used for 
asymmetric hydrogenation for up to 14 times without loss of activity and enantioselectivity.  
5.3 Industrial applications 
Ferofluids have numerous applications in rotary and linear seals as magneto transformers, 
sensors and pressure transducers (flow speed), inertial sensors (acceleration, inclination, and 
gravity) (Vekas, 2008), passive and active bearings, vibration dampers, linear and rotary 
drives, and chemical industry (microtechnologies) as chips, etc. Among the most important 
and commercial applications are developed magnetofluids rotating seals, which are found 
today in a variety of equipments, in electronics, nuclear industry, biotechnology, aeronautics 
and space applications. 
Magnetofluids sealing advantages compared with mechanical seals are: sealing without 
leaking, life time (~ 5 years), only viscous friction, zero contamination, field operation (high 
vacuum (10-8 mbar) at approx. 10 bar), relatively simple construction and low 
manufacturing cost (www.roseal.topnet.ro). 
For seals in dynamic regime, ferrofluids must obey a series of requirements 
(www.roseal.topnet.ro): high saturation magnetization (up to 50 kA/m (approx. 600 g)), 
physical properties adapted to operating conditions, especially in gas pressure and 
temperature sealed, high colloidal stability in intense and powerful magnetic field, 
Newtonian flow properties even in intense magnetic field. 
Ferrofluids should operate at 1500C in continuous system or at temperatures of 2000C in 
intermittent system. They should also work in winter conditions (-200C) or in space 
environment (-550C) and to resist at nuclear radiation.  
Researchers at NASA (Rosensweig et al., 1985) experienced ferrofluids in a spacecraft 
control system. While ferrofluids are used often in commercial processes, for the 
manufacture of CDs to create sophisticated suspension systems for cars, a researcher at 
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NASA (Kodama) (http://www.interactivearchitecture.org/ferrofluid-sculptures-by-
sachiko-kodama.html) choose to use the dynamic qualities of these fluids. Thus, Kodama 
models their shape using a computer to control the electro-magnetic fields and creating 
different forms that continually reinvent themselves without the help of video effect. In the 
printing industry, special inks are used to protect valuable documents, labels, packaging or 
brand. Magnetic ink contains a pigment that produces magnetic pulses detected by 
magnetic reading devices, and messages can be read only by exposure to the equipment 
(http://www.pricon.ro/ro/special.php). 
6. XPS results for core-shell magnetic nanoparticles  
Magnetite particles coated by different Si-containing compounds (monomers and polymers) 
were prepared using co-precipitation method or a free-solvent synthesis. The covered 
magnetite particles were obtained in one step by co-precipitation of iron chloride salts in 
presence of monomers or (co)polymers adequately functionalized, as surfactants. When the 
co-precipitation was in the absence of surfactant, the covered particles were obtained in two 
steps, the first step consisting in the obtaining of magnetite particles and in the second step, 
the magnetite particles being covered with an adequate monomer or (co)polymer, specific 
for the desired application. The magnetite particles covered with aminosilane were obtained 
by replacement of the shell of magnetite-oleic acid particles which were synthesised by a 
free-solvent method. The average diameters of magnetic nanoparticles are depending on the 
synthesis method, are less than 1 µm and the smallest dimensions are obtained by free-
solvent method (Table 2). 
In this chapter we focused on the characterization of core-shell magnetic nanoparticles as 
determined by X-ray photoelectron spectroscopy (XPS). XPS, also known as Electron 
Spectroscopy for Chemical Analysis (ESCA), is an elemental analysis technique and used to 
determine quantitatively the atomic composition and surface chemistry. XPS spectra are 
obtained by irradiating a material with a beam of X-rays while simultaneously measuring 
the kinetic energy and number of electrons that escape from the top 1 to 10 nm of the 
material being analysed (Watts et al., 2003; http://en.wikipedia.org/wiki/X-
ray_photoelectron_spectroscopy).  
The surface of the magnetite particles modified with aminosilane (Ma-APTES) or with 
polydimethylsiloxane–carboxy-terminated poly(ethylene oxide) graft copolymer (Ma-
PDMSgPEO-COOH) was carefully followed using XPS data.  
Hydrophilic magnetite particles (Ma-APTES) were prepared by two methods:  
a. Co-precipitation of Fe2+ and Fe3+ ions in presence of ammoniacal solution according to 
the Massart method (Massart, 1981). The organic-inorganic “core-shell” magnetic 
particles (core: magnetite, shell: aminosilane monomer) were obtained by the 
condensation reaction between the hydroxyl groups on the magnetite surface and the 
ethoxyl groups from silane structure (Figure 6) (Durdureanu-Angheluta et al., 2008);  
b. The replacing, with aminosilane, of oleic acid of magnetite-oleic acid particles which 
were obtained by free-solvent method (Figure 7, Table 2) (Durdureanu-Angheluta et al., 
2011b). 
DLS, SEM and AFM analysis indicated the formation of low polydispersity particles, with a 
spherical morphology and dimensions of nanometers (Table 2).  
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Fig. 6. Schematic principle of covalent bonding between magnetite core and ethoxyl groups 
of silane monomer (Durdureanu-Angheluta et al., 2008). 
 
Fig. 7. Schematic representation of replacement of oleic acid shell with aminosilane 
monomer from magnetite-oleic acid particles (Durdureanu-Angheluta et al., 2011b). 
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Table 2. Coated magnetite particles. 
www.intechopen.com
 Materials Science and Technology 
 
164 
The XPS spectra for Ma-APTES1 (Table 2 and Figure 6) were recorded on a XR6 
monochromated X-ray source (Thermo Scientific Escalab250Xi), with AlKalpha radiation 
and a variable 200-900 µm spot size. Charge correction was performed using C1s at 284.8 eV 
as a reference. The presence of C 1s, O 1s, Si 2p, N 1s, as well Fe 2p peaks in XPS spectra on 
Ma-APTES1 sample give a proof for the chemical structure of aminopropyltrisiloxy coated 
magnetite particles. The Si 2p spectrum (Figure 8) has a peak at 102.4 eV, which is typical of 
silicone atoms, but is also consistent with the oxysilane group expected in the sample.  
 
 
 
Fig. 8. High-resolution Si 2p, C 1p, N 1s, O 1s and Fe 2p XPS spectra for Ma-APTES1 from 
Table 2. 
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C 1s (Figure 8) has two clear peaks, and requires three for a good fit. These have been 
assigned to C-C, C-O/C-N (should really be at least 2 peaks) and a weak peak tentatively 
assigned to O-C=O. N 1s (Figure 8) has two peaks, which appear to represent amine and 
ammonium (or ammonia) in the sample. O 1s (Figure 8) has three peaks, probably from 
different C-O and Si-O states, and also an inorganic oxide which is presumably the 
magnetite. Fe 2p (Figure 8) is extremely weak, so it is difficult to confirm the iron chemistry 
in more detail than “oxide”. 
The structure of Ma-APTES2 coated magnetite nanoparticles (Table 2) was demonstrated by 
X-ray photoelectron spectroscopy (XPS), showing the formation of chemical bonds between 
the surface of magnetite particles and the oxygen atoms of the shells (Durdureanu-
Angheluta et al., 2011b). XPS was performed on a KRATOS Axis Nova (Kratos Analytical, 
Manchester, United Kingdom), using AlKǂ radiation, with 20 mA current and 15 kV voltage 
(300 W), and base pressure of 10-8 to 10-9 Torr in the sample chamber. The incident 
monochromated X-ray beam was focused on a 0.7 mm x 0.3 mm area of the surface. The XPS 
survey spectra for the magnetite sample was collected in the range of -5÷1200 eV with a 
resolution of 1 eV and a pass energy of 160 eV. The high resolution spectra for all the 
elements identified from the survey spectra were collected using pass energy of 20 eV and a 
step size of 0.1 eV. The data were analyzed using the Vision Processing software (Vision2 
software, Version 2.2.8). A linear background was subtracted before the peak areas were 
corrected. The binding energy of the C 1s peak was normalized to 285 eV. 
In Figure 9 the peak at 283.4 eV belonging to the carbon from C-Si, 285.2 eV, was assigned to 
the carbon in the aliphatic chain (C-C) and the peak at 286.6 eV was ascribed to the carbon 
from C-N. The others two small peaks at 287.9 and 289.2 eV belonging to the carboxylate 
(C=O, COO-), were in agreement with the data obtained in the previous literature (Zhang et 
al., 2006), and come from traces of oleic acid. The lack of peak at 290 eV indicates the 
absence of free oleic acid. The bonding energies at 102.3 and 103.0 eV (Figure 10) were the 
characteristic peaks from Si-O and Si-C bonds, respectively. Deconvolution of the N 2p 
peaks (Figure 11) indicated, at 399.3 and 400.8 eV, the presence of amino groups (NH2) and 
tertiary amino groups, respectively. From the deconvolution of O 1s peaks (Figure 12) 
resulted three peaks from magnetite (around 530.8 eV), HO-Fe (around 531.4 eV) (Khurshid 
et al., 2009) and O-Si oxygen bonds (around 532.4 eV).  The peak at around 535 eV could be 
due to the traces of oleic acid in the layer. The bonding energies at 710.6 and 723.7 eV were 
the characteristic peaks from Fe 2p3/2 and Fe 2p1/2, respectively. Deconvolution of the Fe 2p 
has shown the presence of Fe3+ and Fe2+ in both Fe 2p2/3 and Fe 2p1/2 regions (Fe3+ 2p2/3/Fe3+ 
2p1/2: 710.7 eV/724.4 eV; Fe2+ 2p2/3/Fe2+ 2p1/2: 709.2 eV/722 eV). It should be mention that 
an energy difference of 13.1 eV between 2p3/2 and 2p1/2 peaks indicates that the material has, 
as dominant phase, Fe3O4 and, as secondary phase, siloxy-Fe and carboxylate-Fe bonds 
(Zhang et al., 2006). Also, XPS results on the Fe2+/Fe3+ molar ratio of 0.13 (Figure 13) confirm  
the Fe2+/Fe3+ molar ratio used in the synthesis of the magnetite particles (Ma-OA from  
Table 2).  
Hydrophobic magnetite particles (Ma-PDMSgPEO-COOH) were obtained by co-
precipitation of iron salts in water at pH around 11 in the presence of dichloromethane 
solution of siloxane copolymer (PDMSgPEO-COOH) (Figure 10) (Pricop et al., 2010). 
Dimensional analysis of magnetite particles coated with PDMSgPEO-COOH (Table 2) 
showed core-shell morphology of an approximate spherical shape, with an average 
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Fig. 9. High-resolution C 1s XPS spectra for Ma-APTES2 from Table 2 (Durdureanu-
Angheluta et al., 2011b). 
 
Fig. 10. High-resolution Si 2p XPS spectra for Ma-APTES2 from Table 2 (Durdureanu-
Angheluta et al., 2011b). 
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Fig. 11. High-resolution N 1s XPS spectra for Ma-APTES2 from Table 2 (Durdureanu-
Angheluta et al., 2011b). 
 
Fig. 12. High-resolution O 1s XPS spectra for Ma-APTES2 from Table 2 (Durdureanu-
Angheluta et al., 2011b) 
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Fig. 13. High-resolution Fe 2p XPS spectra for Ma-APTES2 from Table 2 (Durdureanu-
Angheluta et al., 2011b) 
diameter of 500 nm. The amphiphilic graft copolymer was proved to be efficient as 
surfactant in the preparation of magnetite particles with a hydrophobic siloxane shell 
(Pricop et al., 2010). 
Ma-PDMSgPEO-COOH particles were analysed on the AXIS Nova X-ray photoelectron 
spectrometer built around the AXIS technology. Data reduction and processing was 
performed using Kratos’ Vision 2 Processing software. 
XPS scans of Si 2p atoms evidenced the appearance of the peaks at around 100 and 102 eV, 
characteristic for Si-O and Si-C bonds, respectively (Figure 15). C 1s atoms present specific 
peaks for CH3-Si, CH2-Si, C-O-C, C-C, C=O, O-C=O (Figure 15) in the 282 to 289 eV interval. 
The deconvolution of O 1s shows the presence of the peak at around 530 eV (Figure 15), 
corresponding to the metallic oxide and the presence of two peaks, with higher binding 
energies due to hydroxyl groups or from the coating of the sample. The deconvolution of Fe 
2p atoms (Figure 15) presents two peaks at 710.7 and 712.8 eV, attributed to Fe3+ 2p2/3 and 
Fe2+ 2p2/3, respectively. 
The presence of peaks at 724.0 and 726.0 eV of  Fe3+ 2p1/2 and Fe2+ 2p1/2, respectively and the 
difference of 13.2 eV between Fe 2p3/2 and Fe 2p1/2 explain the presence of the carboxylate-
Fe bonds (Zhang et. al., 2006).  
It should be underlined that the XPS results were substantiated by FT-IR data, indicating the 
formation of the hydrogen or covalent bonds between the iron oxide substrate and the 
functional group of the surfactant.  
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Fig. 14. Schematic principle of hydrogen bonding between magnetic core and the 
hydrophobic siloxane shell. 
The core-shell magnetic particles present superparamagnetic properties and their saturation 
magnetization values are correlated with those reported by the literature.  
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Fig. 15. High-resolution C 1s, Fe 2p, O 1s and Si 2p spectra for Ma-PDMSgPEO-COOH from 
Table 2.  
7. Conclusion 
Many studies on magnetite particles and their applications in various fields were published. 
This chapter has embedded a few examples, also including our own studies on modified 
magnetite particles with different fictionalizations, specific for the desired application. We 
emphasized the two different methods that can be employed for core-shell particles 
preparation. The results obtained by our group point that free-solvent technique is the more 
versatile one, allowing to obtain particles with smaller sizes and higher stability in magnetic 
fluids, important characteristics for biomedical applications. These materials are very 
promising for the immobilization of biologically active compounds.  
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